Understanding Iron Absorption Physiology
To understand why prioritizing
vitamin C co-administration is correct, it is essential to review the physiology of iron absorption. Dietary iron exists in two forms: heme iron (from animal sources) and non-heme iron (from plant sources and supplements). Most oral iron supplements, such as
ferrous sulfate, provide non-heme iron in the ferric (Fe³⁺) form
[2]. However, the transporter responsible for iron uptake in the duodenum,
divalent metal transporter 1 (DMT1), only recognizes the ferrous (Fe²⁺) form. Therefore, ferric iron must first be reduced to ferrous iron by
duodenal cytochrome B (DcytB), a ferrireductase enzyme whose activity is significantly enhanced by an acidic environment and the presence of reducing agents like ascorbic acid (
vitamin C) [2,3].
Why Option 3 is the Priority Intervention
Encouraging the intake of iron supplements with
vitamin C-rich foods or beverages directly addresses the biochemical bottleneck in iron absorption.
Vitamin C acts as a potent reducing agent, converting ferric iron to the more soluble and absorbable ferrous form, and also chelates iron to keep it soluble in the alkaline pH of the small intestine
[3]. This is a critical point because the bioavailability of non-heme iron is inherently low, and factors in the food matrix can further inhibit absorption
[3]. By pairing the supplement with a source of
vitamin C, the nurse actively facilitates the physiological process required for iron to cross the enterocyte membrane, making this the highest-priority action to promote absorption.
Analysis of Incorrect Options
The other options are incorrect because they either inhibit absorption or are based on a misunderstanding of side effect management versus therapeutic efficacy.
-
Option 1 (Administer with milk): Milk contains calcium and casein, both of which are potent inhibitors of non-heme iron absorption. Calcium competes with iron for the DMT1 transporter, and casein can chelate iron, forming an unabsorbable complex
[3]. While milk might reduce gastric irritation, it would severely compromise the primary therapeutic goal of correcting the
iron deficiency.
-
Option 2 (Take with coffee or tea): Coffee and tea are rich in polyphenols and tannins, which bind non-heme iron in the gut lumen and form insoluble complexes that cannot be absorbed
[3]. This significantly reduces iron bioavailability, making it a contraindicated practice during iron therapy.
-
Option 4 (Take immediately after meals): While taking iron with or after food is a common recommendation to minimize gastrointestinal side effects like nausea and epigastric pain, food contains numerous inhibitors of iron absorption, including phytates (from grains and legumes), polyphenols, and calcium [1,2]. The priority in treating
iron deficiency anemia is to maximize absorption to rapidly correct the deficiency. If side effects are intolerable, administration with a small amount of food can be a secondary strategy, but it is not the priority intervention for promoting absorption. The most effective absorption occurs when the supplement is taken on an empty stomach with an enhancer like
vitamin C [2].
Clinical Application and Safety Note
In clinical practice, the nurse's instruction should be specific. The client should be taught to take their iron supplement with a glass of orange juice, a few slices of tomato, or a small serving of strawberries. This simple dietary pairing directly leverages the DcytB enzymatic pathway to enhance the reduction and subsequent absorption of iron
[2]. It is also important to note that conventional ferrous salts are often poorly tolerated due to gastrointestinal side effects, which can lead to poor adherence [1,2]. Therefore, while managing side effects is a nursing consideration, it does not take precedence over ensuring the drug's efficacy. The nurse should first establish the optimal dosing strategy for absorption and then, if necessary, implement strategies like a gradual dose titration or switching to a formulation with a better tolerability profile, such as
iron protein succinylate, to manage persistent side effects
[2].
References (research sources)
- [2]
Iron Deficiency and Oral Treatments: Limitations, Pharmacokinetics, and the Role of Iron Protein Succinylate in Clinical Practice.Research articleGarcía-Erce JA, García-López S, Martínez-Francés A. (2026) · DOI: 10.3390/jcm15103691
- [3]
Micronutrients in Future Diets: Considerations for Dietary Iron and the Food Matrix Effects on Bioavailability.Research articlePunetha P, O'Callaghan TF, McCarthy EK. (2026) · DOI: 10.1002/mnfr.70483